• Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

  • Jul 10 2024
  • Length: 33 mins
  • Podcast

Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228  By  cover art

Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

  • Summary

  • Improved cancer diagnostics — and improved patient outcomes — could be among the changes generative AI will bring to the healthcare industry, thanks to Paige, the first company with an FDA-approved tool for cancer diagnosis. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Paige cofounder and Chief Scientific Officer Thomas Fuchs. He’s also dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai. Tune in to hear Fuchs on machine learning and AI applications and how technology brings better precision and care to the medical industry.
    Show more Show less
activate_primeday_promo_in_buybox_DT

What listeners say about Paige Cofounder Thomas Fuchs’ Diagnosis on Improving Cancer Patient Outcomes With AI - Ep. 228

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.